The global Cosmetics Safety and Efficacy Testing market is projected to reach US$ 705.4 million in 2029, increasing from US$ 363 million in 2022, with the CAGR of 10.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cosmetics Safety and Efficacy Testing market research.
Cosmetics industry has experienced significant growth on a global level, but not without major challenges. Quality, safety, efficacy and labeling requirements for cosmetic products are regulated differently in various regions, making it difficult to identify relevant regulations and ensure compliance in all countries where cosmetic products are marketed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cosmetics Safety and Efficacy Testing market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
SGS
Eurofins Scientific
Bureau Veritas
Intertek
T脺V S脺D
ALS
CTI
Neogen
China Certification & Inspection
SMQ
CIRS
Iwase Cosfa
Biorius
Segment by Type
Clinical Research Services
Cosmetics Testing to Regulation
Allergen Screening
Microbiology Testing
Ingredients Testing
Others
Segment by Application
Cosmetics
Oral Care Products
Sunscreen
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Cosmetics Safety and Efficacy Testing report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. 麻豆原创 Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: 麻豆原创 Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Cosmetics Safety and Efficacy Testing 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Clinical Research Services
1.2.3 Cosmetics Testing to Regulation
1.2.4 Allergen Screening
1.2.5 Microbiology Testing
1.2.6 Ingredients Testing
1.2.7 Others
1.3 麻豆原创 by Application
1.3.1 Global Cosmetics Safety and Efficacy Testing 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cosmetics
1.3.3 Oral Care Products
1.3.4 Sunscreen
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cosmetics Safety and Efficacy Testing 麻豆原创 Perspective (2018-2029)
2.2 Cosmetics Safety and Efficacy Testing Growth Trends by Region
2.2.1 Global Cosmetics Safety and Efficacy Testing 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cosmetics Safety and Efficacy Testing Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Cosmetics Safety and Efficacy Testing Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Cosmetics Safety and Efficacy Testing 麻豆原创 Dynamics
2.3.1 Cosmetics Safety and Efficacy Testing Industry Trends
2.3.2 Cosmetics Safety and Efficacy Testing 麻豆原创 Drivers
2.3.3 Cosmetics Safety and Efficacy Testing 麻豆原创 Challenges
2.3.4 Cosmetics Safety and Efficacy Testing 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cosmetics Safety and Efficacy Testing Players by Revenue
3.1.1 Global Top Cosmetics Safety and Efficacy Testing Players by Revenue (2018-2023)
3.1.2 Global Cosmetics Safety and Efficacy Testing Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Cosmetics Safety and Efficacy Testing 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cosmetics Safety and Efficacy Testing Revenue
3.4 Global Cosmetics Safety and Efficacy Testing 麻豆原创 Concentration Ratio
3.4.1 Global Cosmetics Safety and Efficacy Testing 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cosmetics Safety and Efficacy Testing Revenue in 2022
3.5 Cosmetics Safety and Efficacy Testing Key Players Head office and Area Served
3.6 Key Players Cosmetics Safety and Efficacy Testing Product Solution and Service
3.7 Date of Enter into Cosmetics Safety and Efficacy Testing 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Cosmetics Safety and Efficacy Testing Breakdown Data by Type
4.1 Global Cosmetics Safety and Efficacy Testing Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Cosmetics Safety and Efficacy Testing Forecasted 麻豆原创 Size by Type (2024-2029)
5 Cosmetics Safety and Efficacy Testing Breakdown Data by Application
5.1 Global Cosmetics Safety and Efficacy Testing Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Cosmetics Safety and Efficacy Testing Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Cosmetics Safety and Efficacy Testing 麻豆原创 Size (2018-2029)
6.2 North America Cosmetics Safety and Efficacy Testing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cosmetics Safety and Efficacy Testing 麻豆原创 Size by Country (2018-2023)
6.4 North America Cosmetics Safety and Efficacy Testing 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cosmetics Safety and Efficacy Testing 麻豆原创 Size (2018-2029)
7.2 Europe Cosmetics Safety and Efficacy Testing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cosmetics Safety and Efficacy Testing 麻豆原创 Size by Country (2018-2023)
7.4 Europe Cosmetics Safety and Efficacy Testing 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cosmetics Safety and Efficacy Testing 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Cosmetics Safety and Efficacy Testing 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cosmetics Safety and Efficacy Testing 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Cosmetics Safety and Efficacy Testing 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cosmetics Safety and Efficacy Testing 麻豆原创 Size (2018-2029)
9.2 Latin America Cosmetics Safety and Efficacy Testing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cosmetics Safety and Efficacy Testing 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Cosmetics Safety and Efficacy Testing 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cosmetics Safety and Efficacy Testing 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Cosmetics Safety and Efficacy Testing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cosmetics Safety and Efficacy Testing 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Cosmetics Safety and Efficacy Testing 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 SGS
11.1.1 SGS Company Detail
11.1.2 SGS Business Overview
11.1.3 SGS Cosmetics Safety and Efficacy Testing Introduction
11.1.4 SGS Revenue in Cosmetics Safety and Efficacy Testing Business (2018-2023)
11.1.5 SGS Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Detail
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Cosmetics Safety and Efficacy Testing Introduction
11.2.4 Eurofins Scientific Revenue in Cosmetics Safety and Efficacy Testing Business (2018-2023)
11.2.5 Eurofins Scientific Recent Development
11.3 Bureau Veritas
11.3.1 Bureau Veritas Company Detail
11.3.2 Bureau Veritas Business Overview
11.3.3 Bureau Veritas Cosmetics Safety and Efficacy Testing Introduction
11.3.4 Bureau Veritas Revenue in Cosmetics Safety and Efficacy Testing Business (2018-2023)
11.3.5 Bureau Veritas Recent Development
11.4 Intertek
11.4.1 Intertek Company Detail
11.4.2 Intertek Business Overview
11.4.3 Intertek Cosmetics Safety and Efficacy Testing Introduction
11.4.4 Intertek Revenue in Cosmetics Safety and Efficacy Testing Business (2018-2023)
11.4.5 Intertek Recent Development
11.5 T脺V S脺D
11.5.1 T脺V S脺D Company Detail
11.5.2 T脺V S脺D Business Overview
11.5.3 T脺V S脺D Cosmetics Safety and Efficacy Testing Introduction
11.5.4 T脺V S脺D Revenue in Cosmetics Safety and Efficacy Testing Business (2018-2023)
11.5.5 T脺V S脺D Recent Development
11.6 ALS
11.6.1 ALS Company Detail
11.6.2 ALS Business Overview
11.6.3 ALS Cosmetics Safety and Efficacy Testing Introduction
11.6.4 ALS Revenue in Cosmetics Safety and Efficacy Testing Business (2018-2023)
11.6.5 ALS Recent Development
11.7 CTI
11.7.1 CTI Company Detail
11.7.2 CTI Business Overview
11.7.3 CTI Cosmetics Safety and Efficacy Testing Introduction
11.7.4 CTI Revenue in Cosmetics Safety and Efficacy Testing Business (2018-2023)
11.7.5 CTI Recent Development
11.8 Neogen
11.8.1 Neogen Company Detail
11.8.2 Neogen Business Overview
11.8.3 Neogen Cosmetics Safety and Efficacy Testing Introduction
11.8.4 Neogen Revenue in Cosmetics Safety and Efficacy Testing Business (2018-2023)
11.8.5 Neogen Recent Development
11.9 China Certification & Inspection
11.9.1 China Certification & Inspection Company Detail
11.9.2 China Certification & Inspection Business Overview
11.9.3 China Certification & Inspection Cosmetics Safety and Efficacy Testing Introduction
11.9.4 China Certification & Inspection Revenue in Cosmetics Safety and Efficacy Testing Business (2018-2023)
11.9.5 China Certification & Inspection Recent Development
11.10 SMQ
11.10.1 SMQ Company Detail
11.10.2 SMQ Business Overview
11.10.3 SMQ Cosmetics Safety and Efficacy Testing Introduction
11.10.4 SMQ Revenue in Cosmetics Safety and Efficacy Testing Business (2018-2023)
11.10.5 SMQ Recent Development
11.11 CIRS
11.11.1 CIRS Company Detail
11.11.2 CIRS Business Overview
11.11.3 CIRS Cosmetics Safety and Efficacy Testing Introduction
11.11.4 CIRS Revenue in Cosmetics Safety and Efficacy Testing Business (2018-2023)
11.11.5 CIRS Recent Development
11.12 Iwase Cosfa
11.12.1 Iwase Cosfa Company Detail
11.12.2 Iwase Cosfa Business Overview
11.12.3 Iwase Cosfa Cosmetics Safety and Efficacy Testing Introduction
11.12.4 Iwase Cosfa Revenue in Cosmetics Safety and Efficacy Testing Business (2018-2023)
11.12.5 Iwase Cosfa Recent Development
11.13 Biorius
11.13.1 Biorius Company Detail
11.13.2 Biorius Business Overview
11.13.3 Biorius Cosmetics Safety and Efficacy Testing Introduction
11.13.4 Biorius Revenue in Cosmetics Safety and Efficacy Testing Business (2018-2023)
11.13.5 Biorius Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
SGS
Eurofins Scientific
Bureau Veritas
Intertek
T脺V S脺D
ALS
CTI
Neogen
China Certification & Inspection
SMQ
CIRS
Iwase Cosfa
Biorius
听
听
*If Applicable.
